Abstract
Consensus recommendations for use of gastroprotective therapy in patients who take aspirin, other nonsteroidal anti-inflammatory drugs (NSAIDs; including cyclooxygenase inhibitors), or clopidogrel have been released by the American College of Cardiology, the American Heart Association, and the American College of Gastroenterology. Antiplatelet therapies are associated with well-recognized complications, including …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
